Home › Funds › GREAT POINT PARTNERS LLC › DBVT

GREAT POINT PARTNERS LLC position in DBVT

DBV TECHNOLOGIES S A · Health Care

GREAT POINT PARTNERS LLC reported holding 156,906 shares of DBVT (DBV TECHNOLOGIES S A) in its Q2 2026 13F filing — a position valued at US$2.6M, representing 0.54% of its reported portfolio and ranking #39 among its reported holdings. GREAT POINT PARTNERS LLC has disclosed DBVT holdings in 3 of the last 5 reported quarters, going back to Q2 2025.

Latest position (Q2 2026)156.91K sh
Reported value held$2.57M
Portfolio Weight0.54%
First reportedQ2 2025
Last changeNew
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How GREAT POINT PARTNERS LLC's DBVT position evolved

GREAT POINT PARTNERS LLC first disclosed a stake in DBVT in Q2 2025 at 374,679 shares (US$3.4M). The position peaked in Q3 2025 at 378,594 shares, worth US$3.8M. Across 3 filings, GREAT POINT PARTNERS LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 156,906 shares valued at US$2.6M.

Quarter by quarter

QuarterSharesValueChange
Q2 2025 374.68K $3.43M New
Q3 2025 378.59K $3.79M Add
Q2 2026 156.91K $2.57M New

Dots on the line are colored by change type; missing quarters mean no position was reported.

About DBVT and 13F data

DBVT (DBV TECHNOLOGIES S A) is a Health Care company. 57 other funds we track also report a position in DBVT — the largest reported positions include MPM BioImpact LLC (US$60.1M), Siren, L.L.C. (US$30.5M), Vivo Capital, LLC (US$30.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding DBVT

All DBVT fund holders →

FAQ

How long has GREAT POINT PARTNERS LLC held DBVT?

GREAT POINT PARTNERS LLC has disclosed DBVT holdings in 3 of the last 5 reported quarters, going back to Q2 2025.

What is GREAT POINT PARTNERS LLC's current position in DBVT?

As of Q2 2026, GREAT POINT PARTNERS LLC holds 156.91K shares of DBVT (DBV TECHNOLOGIES S A), valued at $2.57M, representing 0.54% of its reported portfolio and ranking #39.

Has GREAT POINT PARTNERS LLC been buying or selling DBVT?

In the latest 13F filing (Q2 2026), GREAT POINT PARTNERS LLC newly opened its position in DBVT. The position peaked in Q3 2025 at 378.59K shares.

Which other funds hold DBVT?

Other major institutional holders of DBVT include MPM BioImpact LLC, Siren, L.L.C., Vivo Capital, LLC, among 57 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.